Genteric
Redwood City
About Genteric
Genteric, Inc. develops gene-based drug delivery that employs the secretor organs of the patient’s gastrointestinal system to produce and release therapeutic proteins into the bloodstream.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Total funding: $31.0M
- Funding stage: Early Stage Venture
- Last round: Series B (Apr 2001)
Industries & Categories
Biotechnology, Medical, Therapeutics
Canonical: https://fsome.com/organization/genteric-2054284 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.